< 1 minute read
Sep. 18, 2021

AG-636: A Dihydroorotate Dehydrogenase Inhibitor

AG-636

dihydroorotate dehydrogenase inhibitor in Ph. I for RR-lymphoma from opt. of literature molecule Mol. Cancer Ther., Oct. 20, 2020 Agios Pharmaceuticals, Cambridge, MA

drughunter.com
Drug Hunter Team

AG-636 (Agios Pharmaceuticals dihydroorotate dehydrogenase (DHODH) inhibitor clinical candidate)

Loading...

twitterlinkedinemail

Other molecules you may be interested in